Abbott Reports Fourth-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Abbott Labs (ABT) PT Raised to $68 at Leerink Partners
January 25, 2018 7:16 AM ESTLeerink Partners raised its price target on Abbott Labs (NYSE: ABT) to $68.00 (from $60.00) while maintaining a Outperform rating.
... MoreAbbott Labs (ABT) PT Raised to $71 at Stifel
January 24, 2018 4:42 PM ESTStifel raised its price target on Abbott Labs (NYSE: ABT) to $71.00 (from $63.00) while maintaining a Buy rating following strong Q4 results.
Analyst Rick Wise said the company has significant and sustainable momentum heading into 2018.
... MoreAbbott Labs (ABT) PT Raised to $67 at Evercore ISI
January 24, 2018 12:34 PM ESTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $67.00 (from $64.00) while maintaining a Outperform rating.
The firm raised FY2018 EPS from $2.82 to $2.87, trimmed FY 2019 from $3.23 to $3.22 and raised FY 2020 from $3.55 to $3.56.
... MoreAbbott (ABT) Tops Q4 EPS by 1c, Offers FY18 Guidance
January 24, 2018 7:48 AM ESTAbbott (NYSE: ABT) reported Q4 EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $7.6 billion versus the consensus estimate of $7.39 billion.
GUIDANCE:
Abbott sees FY2018 EPS of $2.80-$2.90, versus the consensus of $2.83.
Abbott is... More